Literature DB >> 14612991

Antiarrhythmic effect of ischemic preconditioning in recent unstable angina patients undergoing coronary artery bypass grafting.

Zhong-Kai Wu1, Tiina Iivainen, Erkki Pehkonen, Jari Laurikka, Matti R Tarkka.   

Abstract

Coronary artery bypass grafting (CABG) for unstable angina pectoris patients results in a higher incidence of arrhythmia and higher arrhythmic cardiac mortality. Ischemic preconditioning (IP) has proved effective in suppressing ischemia reperfusion arrhythmias in animals and in humans. The purpose of the present study was to investigate whether IP protects against postoperative arrhythmias in recent unstable angina patients undergoing urgent CABG. Forty-one patients with recent unstable angina and three-vessel coronary artery disease admitted for CABG were randomized into an IP group and a control group. The IP protocol involved twice occluding the ascending aorta with a cross-clamp for 2 minutes, followed by 3 minutes of reperfusion. Twenty-four-hour continuous electrocardiography (24-h ECG) was recorded from the preoperative day to the 2nd postoperative day. The incidences of supraventricular extrasystole (SVES), ventricular extrasystole (VES), supraventricular tachycardia (SVT), and ventricular tachycardia (VT) were 95.2%, 85.7%, 26.2%, and 26.2%, respectively, before surgery and 100.0%, 100.0%, 88.1%, and 76.2%, respectively, after surgery. IP significantly reduced the incidence of VT and the severity of SVES, VES, SVT, and VT after surgery. The period of mechanical ventilation and the length of stay in the intensive care unit were significantly shorter in the IP group. In summary, rhythm disturbances are common in CABG patients with recent unstable angina. IP significantly reduces rhythm disturbances, including SVES, VES, SVT, and VT after CABG. The findings indicate that IP could constitute an additional myocardial protective strategy in recently unstable angina patients undergoing CABG.

Entities:  

Mesh:

Year:  2003        PMID: 14612991     DOI: 10.1007/s00268-003-6861-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  22 in total

1.  Ischaemic preconditioning has a beneficial effect on left ventricular haemodynamic function after a coronary artery biopass grafting operation.

Authors:  Z K Wu; M R Tarkka; E Pehkonen; L Kaukinen; E L Honkonen; S Kaukinen
Journal:  Scand Cardiovasc J       Date:  2000-06       Impact factor: 1.589

2.  Rhythm disturbances after blood and crystalloid cardioplegia in coronary artery bypass grafting.

Authors:  E J Pehkonen; P M Reinikainen; M J Kataja; M R Tarkka
Journal:  Scand J Thorac Cardiovasc Surg       Date:  1995

3.  Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features.

Authors:  E Deutsch; M Berger; W G Kussmaul; J W Hirshfeld; H C Herrmann; W K Laskey
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

4.  Effect of ischemic preconditioning on myocardial protection in coronary artery bypass graft patients : can the free radicals act as a trigger for ischemic preconditioning?

Authors:  Z K Wu; M R Tarkka; J Eloranta; E Pehkonen; L Kaukinen; E L Honkonen; S Kaukinen
Journal:  Chest       Date:  2001-04       Impact factor: 9.410

5.  Adenosine preconditioning reduces both pre and postischemic arrhythmias in human myocardium.

Authors:  B J Pomerantz; K Joo; B D Shames; J C Cleveland; A Banerjee; A H Harken
Journal:  J Surg Res       Date:  2000-05-15       Impact factor: 2.192

6.  Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization.

Authors:  D J Patel; H J Purcell; K M Fox
Journal:  Eur Heart J       Date:  1999-01       Impact factor: 29.983

7.  Antiarrhythmic effect of repeated coronary occlusion during balloon angioplasty.

Authors:  K E Airaksinen; H V Huikuri
Journal:  J Am Coll Cardiol       Date:  1997-04       Impact factor: 24.094

8.  Stenosis of the right coronary artery and retrograde cardioplegia predispose patients to atrial fibrillation after coronary artery bypass grafting.

Authors:  E Pehkonen; E Honkonen; P Mäkynen; M Kataja; M Tarkka
Journal:  Thorac Cardiovasc Surg       Date:  1998-06       Impact factor: 1.827

9.  Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease.

Authors:  W Zareba; A J Moss; S le Cessie
Journal:  Am J Cardiol       Date:  1994-09-15       Impact factor: 2.778

Review 10.  Arrhythmias and conduction disturbances after coronary artery bypass graft surgery: epidemiology, management, and prognosis.

Authors:  L A Pires; A B Wagshal; R Lancey; S K Huang
Journal:  Am Heart J       Date:  1995-04       Impact factor: 4.749

View more
  3 in total

1.  Effect of remote ischemic conditioning on atrial fibrillation and outcome after coronary artery bypass grafting (RICO-trial).

Authors:  Daniel Brevoord; Markus W Hollmann; Stefan G De Hert; Eric Hpa van Dongen; Bram Gadh Heijnen; Anton de Bruin; Noortje Tolenaar; Wolfgang S Schlack; Nina C Weber; Marcel Gw Dijkgraaf; Joris R de Groot; Bas Ajm de Mol; Antoine Hg Driessen; Mona Momeni; Patrick Wouters; Stefaan Bouchez; Jan Hofland; Christan Lüthen; Tanja A Meijer-Treschan; Benedikt H Pannen; Benedikt Preckel
Journal:  BMC Anesthesiol       Date:  2011-05-23       Impact factor: 2.217

2.  New technique of local ischemic preconditioning induction without repetitive aortic cross-clamping in cardiac surgery.

Authors:  Dmitry I Kurapeev; Viktor O Kabanov; Vadim K Grebennik; Tatyana A Sheshurina; Vladimir V Dorofeykov; Michael M Galagudza; Eugene V Shlyakhto
Journal:  J Cardiothorac Surg       Date:  2015-01-22       Impact factor: 1.637

3.  Preconditioning or Postconditioning with 8-Br-cAMP-AM Protects the Heart against Regional Ischemia and Reperfusion: A Role for Mitochondrial Permeability Transition.

Authors:  Igor Khaliulin; Raimondo Ascione; Leonid N Maslov; Haitham Amal; M Saadeh Suleiman
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.